| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/29/1997 | US5652130 Retroviral vectors expressing tumor necrosis factor (TNF) |
| 07/29/1997 | US5652123 Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 07/29/1997 | US5652120 Gene coding human epidermal growth factor and process for preparing the same |
| 07/29/1997 | US5652119 Recombinant feline herpesvirus vaccine |
| 07/29/1997 | US5652116 Method for genetically manipulating peptide synthetases |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |
| 07/29/1997 | US5652112 Assay for type I collagen carboxy-terminal telopeptide analytes |
| 07/29/1997 | US5652110 Antibodies to αvβ3 integrin |
| 07/29/1997 | US5652109 Antitumor agents; medical diagnosis |
| 07/29/1997 | US5652100 Stably transfected rodent fibroblast cell lines expressing human GABA-A -receptors |
| 07/29/1997 | US5652092 Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of β-amyloid peptide |
| 07/29/1997 | US5651969 Enhancing neurite outgrowth and improving nerve regeneration |
| 07/29/1997 | US5651963 Heterodimers forms of CSF-1 and pharmaceutical compositions thereof |
| 07/29/1997 | CA1339188C Removal of protein a from antibody preparations |
| 07/29/1997 | CA1339186C Process for reducing the aggregate content of growth hormone-like materials |
| 07/29/1997 | CA1339111C Antiviral agent |
| 07/29/1997 | CA1339106C Hirullin polypeptides having anticoagulant activity |
| 07/29/1997 | CA1339105C Modified proteins |
| 07/29/1997 | CA1339104C Hirudin derivative |
| 07/29/1997 | CA1339099C Yeast vector |
| 07/29/1997 | CA1339071C Thrombus control agent |
| 07/29/1997 | CA1339068C High molecular weight cell-associated protein of campylobacter pylori |
| 07/29/1997 | CA1339067C Antigenic compositions and methods for their production and use |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026359A1 System for the expression of heterologous antigens as fusion proteins |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026353A1 ALANYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026352A1 STAPHYLOCOCCUS AUREUS SERYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026350A1 STAPHYLOCOCCUS AUREUS METHIONYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026348A1 ASPARAGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026341A1 CYSTEINYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026338A1 Staphylococcus aureus wcuh29 spoiiie protein |
| 07/24/1997 | WO1997026336A1 Compositions for treating anemia |
| 07/24/1997 | WO1997026335A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | WO1997026333A1 Humanized green fluorescent protein genes and methods |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026330A2 Morphological mutants of filamentous fungi |
| 07/24/1997 | WO1997026326A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
| 07/24/1997 | WO1997026320A2 Product for inhibition of attachment of h. influenzae to human cells |
| 07/24/1997 | WO1997026274A1 Leptospiral outer membrane proteins |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026010A1 Anticoagulant agents useful in treatment of thrombosis |
| 07/24/1997 | WO1997026006A1 Compositions and methods for administering borrelia burgdorferi antigens |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | WO1997018300A3 Murine model for human carcinoma |
| 07/24/1997 | WO1997010258A3 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | CA2844461A1 Compositions for treating anemia |
| 07/24/1997 | CA2248638A1 Methods and compositions for inhibiting hexokinase |
| 07/24/1997 | CA2243531A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | CA2243470A1 Recombinant aav virion for expressing epo in a mammal |
| 07/24/1997 | CA2243446A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | CA2234680A1 Product for inhibition of attachment of h. influenzae to human cells |
| 07/24/1997 | CA2215900A1 Leptospiral outer membrane proteins |
| 07/24/1997 | CA2214840A1 System for the expression of heterologous antigens as fusion proteins |
| 07/23/1997 | EP0785432A1 Method for the immunological identification or determination of polypeptide antigens |
| 07/23/1997 | EP0785276A1 Modification of peptide and protein |
| 07/23/1997 | EP0785274A1 An artifical recombinant substrate (rAGG-1) and native aggrecan to study the proteolytic activity of 'Aggrecanase' in cell culture systems |
| 07/23/1997 | EP0785273A1 Paired basic amino acid converting enzyme and DNA sequence encoding it |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785270A1 Staphylococcus aureus Seryl-tRNA synthetase |
| 07/23/1997 | EP0785268A1 Staphylococcus aureus methionyl-tRNA synthetase |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785260A1 Alanyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785259A1 Asparaginyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0785257A1 Cysteinyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0784689A1 Microorganisms as therapeutic delivery systems |
| 07/23/1997 | EP0784685A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 07/23/1997 | EP0784683A1 Tie-2 ligands, methods of making and uses thereof |
| 07/23/1997 | EP0784682A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/23/1997 | EP0784680A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 07/23/1997 | EP0784678A1 Genes encoding signal recognition particle of aspergillus niger |
| 07/23/1997 | EP0784676A1 Neutralization of foof allergens by thioredoxin |
| 07/23/1997 | EP0784632A1 Process for extracting high-purity von willebrand factor |
| 07/23/1997 | EP0784631A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0784482A2 Methods for inhibiting antigen specific t cell responses |
| 07/23/1997 | EP0784479A1 Inhibition of human rotavirus infection |
| 07/23/1997 | EP0784477A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 07/23/1997 | EP0654092A4 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes. |
| 07/23/1997 | EP0638174B1 Measles virus-specific antibody detection using recombinant measles proteins |
| 07/23/1997 | EP0586617B1 Anti-CD3 aglycosylated IgG Antibody |
| 07/23/1997 | EP0502968B1 Activatable fibrinolytic and anti-thrombotic proteins |
| 07/23/1997 | EP0474846B1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides |
| 07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/23/1997 | CN1154970A Antibiotic peptide and production method and application thereof |
| 07/22/1997 | US5650504 Nucleic acids encoding eck receptor ligands |
| 07/22/1997 | US5650500 Dna or rna which hybridizes for sequences |